CAS RN: 24294-89-1
[1,2,5]Oxadiazolo[3,4-b]pyrazine-5,6(1H,3H)-dione(9CI)
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260303
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 24294-89-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Shenzhen
Inquiry
24294-89-1 / 4,7-dihydro-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-dione
Standard CAS: 24294-89-1
Multi CAS: No
Basic Information
copy
CAS
24294-89-1 copy
Multi CAS
No copy
Molecular Formula
C4H2N4O3 copy
Molecular Weight
154.080000 copy
Exact Mass
154.012690 copy
SMILES
C12=NON=C1NC(=O)C(=O)N2 copy
InChI
InChI=1S/C4H2N4O3/c9-3-4(10)6-2-1(5-3)7-11-8-2/h(H,5,7,9)(H,6,8,10) copy
InChIKey
AFJDXTDPQNIWOX-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
9 copy
H-bond acceptors
5 copy
H-bond donors
2 copy
Molar refractivity
33.05 copy
TPSA
104.64 copy
LogP / Solubility
WLOGP
-1.4 copy
MLOGP
-1.24 copy
XLogP3
-1.1 copy
Consensus LogP
-1.25 copy
Log S (ESOL)
-0.52 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
0.19 copy
Class (Ali)
Highly soluble copy
Log S (SILICOS-IT)
0.5 copy
Class (SILICOS-IT)
Highly soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.65 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy